focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,016.00
Bid: 1,014.00
Ask: 1,018.00
Change: -16.00 (-1.55%)
Spread: 4.00 (0.394%)
Open: 1,046.00
High: 1,046.00
Low: 1,006.00
Prev. Close: 1,032.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

16 Nov 2010 07:00

RNS Number : 2224W
CVS Group plc
16 November 2010
 



Tuesday 16th November 2010

CVS Group plc ("CVS" or the "Company")

Acquisition

CVS Group plc

 

 

Acquisition of St David's Veterinary Hospital

 

CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of St David's Veterinary Hospital (SDVH). SDVH is the centre of the small animal part of the St David's Veterinary group, one of the longest established and largest veterinary groups in the UK. It split into different speciality groups many years ago and the Small Animal Hospital is renowned throughout the South West as a leading centre for orthopaedic surgery. Peter Attenburrow will remain in charge of the business and will concentrate on his orthopaedic skills, with CVS providing full managerial support. This should result in improved capacity and services to the many referring practices that send cases to St David's for treatment.

The acquisition brings the total number of surgeries acquired to date in 2010 to 45 including a laboratory and a referral centre.

In total the group now operates 214 surgeries, 6 diagnostic labs, 1 pet crematorium and an online dispensary across the UK and remains the largest operator in a highly fragmented market.

The acquisition of SDVH is deemed to be a substantial transaction under the AIM Rules.

In the year ended 31 July 2009, SDVH achieved profit before tax of approximately £430,000 on turnover of approximately £1,858,000. The Company is acquiring the trade and assets of both St David's Veterinary Group and St David's Veterinary Clinic Limited and includes fixed assets of approximately £122,000 as at 31 July 2009. The consideration for the acquisition is £1,900,000 which includes £300,000 of deferred consideration but excludes payment in respect of stock and is being met entirely from existing cash resources. The practice employs 7 professional vets and 28 staff in total.

Commenting on the acquisition, CVS Chief Executive Simon Innes said: "SDVH is a long established business and we are delighted to be continuing to add to our portfolio following our acquisitions earlier in the year. We look forward to working with the team at St David's to help continue the high level of animal care and customer service that they have been delivering to date."

For further enquiries please contact:

 

CVS Group plc

 

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

 

 

Brewin Dolphin

 

Matt Davis

0845 213 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFEDLTLELII
Date   Source Headline
1st May 20247:00 amRNSAppointment of Non-executive Chair
30th Apr 20247:00 amRNSTotal Voting Rights
11th Apr 20245:48 pmRNSStandard form for notification of major holdings
8th Apr 20247:00 amRNSNotice of Cyber Incident
28th Mar 20244:07 pmRNSExercise of Options and Total Voting Rights
12th Mar 20248:06 amRNSResponse to CMA update
29th Feb 20247:00 amRNSExercise of Options and Total Voting Rights
29th Feb 20247:00 amRNSInterim Results
5th Feb 202411:02 amRNSStandard form for notification of major holdings
31st Jan 20247:00 amRNSExercise of Options and Total Voting Rights
29th Jan 20243:41 pmRNSPDMR Dealing
25th Jan 20247:00 amRNSHalf year Trading Update
19th Jan 20242:24 pmRNSExercise of SAYE Options and PDMR Dealing
12th Jan 20241:56 pmRNSExercise of SAYE Options and PDMR Dealing
12th Jan 20247:00 amRNSBlock Listing Interim Review
5th Jan 20242:44 pmRNSReplacement of Director/PDMR Shareholding
5th Jan 202410:25 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options and Total Voting Rights
22nd Dec 20237:48 amRNSBlock Listing Application
30th Nov 20237:00 amRNSExercise of Options and Total Voting Rights
29th Nov 20233:43 pmRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement and Trading Update
24th Nov 20233:56 pmRNSGrant of Options under CVS Group plc
3rd Nov 20237:05 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20234:46 pmRNSExercise of Options and Total Voting Rights
27th Oct 20237:00 amRNSDirectorate Change
13th Oct 20235:21 pmRNSConfirmation of dividend dates
9th Oct 20232:58 pmRNSExercise of Options, PDMR Dealing, EBT and TVR
29th Sep 20237:00 amRNSExercise of Options and Total Voting Rights
21st Sep 20237:00 amRNSFinal results for the year ended 30 June 2023
7th Sep 202310:50 amRNSResponse to CMA review into veterinary market
31st Aug 20237:00 amRNSExercise of Options and Total Voting Rights
31st Jul 20237:00 amRNSTotal Voting Rights
27th Jul 20237:00 amRNSTrading update, AU expansion and UK acquisitions
12th Jul 20237:00 amRNSBlock Listing Interim Review and TVR Update
30th Jun 20237:00 amRNSExercise of Options and Total Voting Rights
22nd Jun 20237:00 amRNSDirectorate Change
31st May 20237:00 amRNSExercise of Options and Total Voting Rights
12th May 20234:41 pmRNSStandard form for notification of major holdings
5th May 20238:53 amRNSBlock Listing Application
2nd May 20237:00 amRNSTotal Voting Rights
31st Mar 20231:39 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTotal Voting Rights
10th Mar 202310:37 amRNSExercise of SAYE Options, PDMR Dealing and TVR
28th Feb 20237:00 amRNSExercise of Options and Total Voting Rights
24th Feb 20237:00 amRNSInterim Results
2nd Feb 20234:42 pmRNSExercise of Options and Total Voting Rights
26th Jan 20237:00 amRNSHalf year Trading Update
11th Jan 20234:31 pmRNSBlock Listing Interim Review and TVR Update
10th Jan 202312:24 pmRNSExercise of SAYE Options and PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.